Skip to content
AtessiaAtessia Life Science Advisors
  • Home
  • Expertise
  • Services
    • Medicines
      • Exploitant – Pharmaceutical establishment
        • Activites related to quality
        • External communications
        • Pharmacovigilance
        • Audits
      • Regulatory & Pharmaceutical Strategy
      • Research & Development Consulting
      • Marketing authorisation
        • Registration: Drafting & Submitting MA files
        • Post-MA lifecycle management
    • Medical devices
    • Consulting subscription
    • Regulatory monitoring
    • Training
  • Strengths
  • News
    • Company
    • Events
    • Regulatory monitoring
  • Blog
  • Contact
  • English
    • Français
    • English

Blog

_Blog

The serialisation system

Lire la suite »
February 20, 2023
_Blog

The APQR review “à la française”

Lire la suite »
February 1, 2023
_Blog

The consulting profession at ATESSIA

Lire la suite »
January 24, 2023
_Blog

The mysterious thing that an Exploitant is

Lire la suite »
July 7, 2022
_Blog

Registering gene therapy medicinal products

Lire la suite »
June 23, 2022
_Blog

How to manage a non-GMP raw material in your MA files?

Lire la suite »
June 20, 2022
Page1 Page2

ATESSIA, Life Science Advisors
3, Rue d’Uzès – 75002 PARIS
hello@atessia.fr
+33 1.70.22.66.19

Atessia Life Science Advisors

Follow-us

Legal notices

Terms and Conditions of Sale

ATESSIA SAS with capital of €5,000.00 I RCS PARIS 827 777 319

Copyright © 2021 | Powered by Atessia